KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biolife Solutions (BLFS) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Biolife Solutions (BLFS) over the last 9 years, with Q3 2025 value amounting to $700000.0.

  • Biolife Solutions' Amortization - Intangibles changed 0.0% to $700000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 8498.32%. This contributed to the annual value of $2.7 million for FY2024, which is 2224.43% down from last year.
  • Latest data reveals that Biolife Solutions reported Amortization - Intangibles of $700000.0 as of Q3 2025, which was down 0.0% from $708000.0 recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' Amortization - Intangibles registered a high of $2.9 million during Q1 2022, and its lowest value of -$4.2 million during Q4 2022.
  • Its 5-year average for Amortization - Intangibles is $1.1 million, with a median of $933000.0 in 2021.
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first skyrocketed by 25764.87% in 2021, then tumbled by 24800.84% in 2022.
  • Quarter analysis of 5 years shows Biolife Solutions' Amortization - Intangibles stood at $2.9 million in 2021, then crashed by 248.01% to -$4.2 million in 2022, then surged by 85.48% to -$615000.0 in 2023, then surged by 203.58% to $637000.0 in 2024, then grew by 9.89% to $700000.0 in 2025.
  • Its Amortization - Intangibles was $700000.0 in Q3 2025, compared to $708000.0 in Q2 2025 and $702000.0 in Q1 2025.